Literature DB >> 21281464

Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care.

Isabel Del-Cura González1, Francisca García-de-Blas González, Teresa Sanz Cuesta, Jesús Martín Fernández, Justo M Del-Alamo Rodríguez, Rosa A Escriva Ferrairo, M Del Canto De-Hoyos Alonso, Laura Balsalobre Arenas, Ricardo Rodríguez Barrientos, Elisa Ceresuela Wiesmann, Cristina De-Alba Romero, Yolanda Ginés Díaz, Ana Pastor Rodríguez-Moñino, Blanca Gutiérrez Teira, Marta Sánchez-Celaya Del Pozo, Jesús Fernández Horcajuelo, María J Rojas Giraldo, Paulino Cubero González, Rocío A Vello Cuadrado, Beatriz López Uriarte, Jeannet Sánchez Yepes, Yolanda Hernando Sanz, M José Iglesias Piñeiro, Susana Tudanca Hernández, Fernando Gallardo Alonso, Ana I González González, Alicia Simón Fernández, Carmen Carballo, Ana Rey López, Fernanda Morales, Dolores Martínez López.   

Abstract

BACKGROUND: Vaginitis is a common complaint in primary care. In uncomplicated candidal vaginitis, there are no differences in effectiveness between oral or vaginal treatment. Some studies describe that the preferred treatment is the oral one, but a Cochrane's review points out inconsistencies associated with the report of the preferred way that limit the use of such data. Risk factors associated with recurrent vulvovaginal candidiasis still remain controversial. METHODS/
DESIGN: This work describes a protocol of a multicentric prospective observational study with one year follow up, to describe the women's reasons and preferences to choose the way of administration (oral vs topical) in the treatment of not complicated candidal vaginitis. The number of women required is 765, they are chosen by consecutive sampling. All of whom are aged 16 and over with vaginal discharge and/or vaginal pruritus, diagnosed with not complicated vulvovaginitis in Primary Care in Madrid.The main outcome variable is the preferences of the patients in treatment choice; secondary outcome variables are time to symptoms relief and adverse reactions and the frequency of recurrent vulvovaginitis and the risk factors. In the statistical analysis, for the main objective will be descriptive for each of the variables, bivariant analysis and multivariate analysis (logistic regression).. The dependent variable being the type of treatment chosen (oral or topical) and the independent, the variables that after bivariant analysis, have been associated to the treatment preference. DISCUSSION: Clinical decisions, recommendations, and practice guidelines must not only attend to the best available evidence, but also to the values and preferences of the informed patient.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281464      PMCID: PMC3048533          DOI: 10.1186/1471-2458-11-63

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  28 in total

1.  Evidence-based medicine. A new approach to teaching the practice of medicine.

Authors: 
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

Review 2.  Risk factors for Candida vulvovaginitis.

Authors:  B D Reed
Journal:  Obstet Gynecol Surv       Date:  1992-08       Impact factor: 2.347

Review 3.  Diagnosis of vaginitis.

Authors:  M E Egan; M S Lipsky
Journal:  Am Fam Physician       Date:  2000-09-01       Impact factor: 3.292

4.  A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial.

Authors: 
Journal:  Br J Obstet Gynaecol       Date:  1989-02

5.  Single-dose oral fluconazole versus single-dose topical miconazole for the treatment of acute vulvovaginal candidosis.

Authors:  A M van Heusden; H M Merkus; R S Corbeij; H P Oosterbaan; J E Stoot; H M Ubachs; A Verhoeff
Journal:  Acta Obstet Gynecol Scand       Date:  1990       Impact factor: 3.636

6.  Single blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and 1% cream in treating acute vaginal candidosis.

Authors:  J S Bingham
Journal:  Br J Vener Dis       Date:  1984-06

7.  Perception of the economic value of primary care services: a Willingness to Pay study.

Authors:  Jesús Martín-Fernández; Tomás Gómez-Gascón; Juan Oliva-Moreno; María Isabel del Cura-González; Julia Domínguez-Bidagor; Milagros Beamud-Lagos; Teresa Sanz-Cuesta
Journal:  Health Policy       Date:  2009-11-28       Impact factor: 2.980

8.  Treatment of candidal vaginitis. A prospective randomized investigator-blind multicenter study comparing topically applied econazole with oral fluconazole.

Authors:  S Osser; A Haglund; L Weström
Journal:  Acta Obstet Gynecol Scand       Date:  1991       Impact factor: 3.636

9.  Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis.

Authors:  G E Stein; S Christensen; N Mummaw
Journal:  DICP       Date:  1991-06

10.  Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole.

Authors:  J M Tobin; P Loo; S E Granger
Journal:  Genitourin Med       Date:  1992-02
View more
  3 in total

Review 1.  Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment.

Authors:  Natália Martins; Isabel C F R Ferreira; Lillian Barros; Sónia Silva; Mariana Henriques
Journal:  Mycopathologia       Date:  2014-05-01       Impact factor: 2.574

2.  Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented.

Authors:  Sujit D Rathod; Patricia A Buffler
Journal:  BMC Womens Health       Date:  2014-03-10       Impact factor: 2.809

Review 3.  A Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis.

Authors:  April W Armstrong; Michael Bukhalo; Andrew Blauvelt
Journal:  Am J Clin Dermatol       Date:  2016-08       Impact factor: 7.403

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.